Balyasny Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Buy |
+197,569
| New | +$3.16M | ﹤0.01% | 1030 |
|
|
2024
Q1 | – | Sell |
-9,783
| Closed | -$412K | – | 2190 |
|
|
2023
Q4 | $412K | Buy |
+9,783
| New | +$412K | ﹤0.01% | 1492 |
|
|
2023
Q3 | – | Sell |
-255,677
| Closed | -$4.85M | – | 1976 |
|
|
2023
Q2 | $4.85M | Buy |
+255,677
| New | +$4.85M | 0.01% | 789 |
|
|
2023
Q1 | – | Sell |
-375,775
| Closed | -$6.67M | – | 2409 |
|
|
2022
Q4 | $6.67M | Buy |
375,775
+222,272
| +145% | +$3.95M | 0.02% | 679 |
|
|
2022
Q3 | $857K | Buy |
+153,503
| New | +$857K | ﹤0.01% | 1432 |
|
|
2022
Q2 | – | Sell |
-14,616
| Closed | -$81K | – | 2481 |
|
|
2022
Q1 | $81K | Buy |
+14,616
| New | +$81K | ﹤0.01% | 1818 |
|
|
2021
Q1 | – | Sell |
-59,974
| Closed | -$2.77M | – | 1722 |
|
|
2020
Q4 | $2.77M | Buy |
+59,974
| New | +$2.77M | 0.02% | 678 |
|